Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Food Scene
Community Directory
Community Service
Restaurant Guide
Rescue Me
Other
Specials
Entertainment Now
Spring Wellness
Home & Garden
Home Improvement
Home & Realty
Horizons
Outdoor Guide
Progress
Women
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2022 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astrazeneca Plc ADR
(NQ:
AZN
)
64.29
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
47,845
Open
64.29
Bid (Size)
65.23 (21)
Ask (Size)
65.27 (19)
Prev. Close
64.29
Today's Range
64.29 - 64.29
52wk Range
52.65 - 72.12
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Beat the Dow Jones With This Unstoppable Dividend Stock
Today 5:50 EST
This pharmaceutical company has outperformed the Dow Jones index over the last 10 years.
Via
The Motley Fool
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aiming to Capture Significant Market Share for Treatment and Prevention of COVID-19 Illness with Innovative Inhaled NanoAb
February 06, 2023
Via
Investor Brand Network
Exposures
COVID-19
Product Safety
Performance
YTD
-7.27%
-7.27%
1 Month
-9.32%
-9.32%
3 Month
+4.83%
+4.83%
6 Month
-2.43%
-2.43%
1 Year
+13.43%
+13.43%
More News
Read More
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
Via
Benzinga
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
Via
The Motley Fool
Top 5 Health Care Stocks That May Rally
February 03, 2023
Via
Benzinga
AZN Stock Under Pressure
January 23, 2023
Via
Talk Markets
The Top Healthcare Stocks to Buy With $100
January 23, 2023
Via
The Motley Fool
Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst
February 02, 2023
Via
Benzinga
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
February 02, 2023
From
AstraZeneca
Via
Business Wire
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
February 01, 2023
Via
The Motley Fool
These 2 Healthcare Stocks Have Doubled in 2023
February 01, 2023
Via
MarketBeat
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
Via
Benzinga
Cassava Sciences Stock Undervalued with Its $124 Price Target?
January 30, 2023
Via
MarketBeat
Exposures
Product Safety
Could This Vaccine Become Sanofi's Latest Blockbuster?
January 29, 2023
Via
The Motley Fool
Could This Be Novartis' Next Blockbuster Medicine?
January 27, 2023
Via
The Motley Fool
7 Dividend Stocks to Buy for a Stable Income Stream
January 27, 2023
Via
InvestorPlace
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Via
MarketBeat
Exposures
Product Safety
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
Via
The Motley Fool
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
January 23, 2023
From
AstraZeneca
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 20, 2023
From
Brodsky & Smith LLC
Via
Globe NewsWire
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
January 19, 2023
Via
Investor's Business Daily
AstraZeneca’s Next “Wonder Drug”
January 19, 2023
Via
Talk Markets
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
January 19, 2023
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via
MarketBeat
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
January 18, 2023
From
HUTCHMED (China) Limited
Via
Globe NewsWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.